In addition to providing the most outstanding care possible for our patients today, we are also leaders in improving outcomes for patients in the future. The research in our Division spans the spectrum from basic through clinical research with a shared goal of understanding and ultimately developing more effective means for treating pediatric hematology and oncology disorders.
Our clinical research program includes a large number of clinical trials for children with cancer, blood disorders, and diseases treated using bone marrow transplantation. For children with sickle cell disease, we are studying approaches that may help improve control of symptoms, as well as definitive methods to cure the disease. For children with cancer, our clinical research program brings the latest therapies to every child we treat. Our precision medicine program allows us to tailor therapies based on state of the art technologies. We also have active studies focused on decreasing the side effects of treatment.
Explore our clinical research initiatives
Basic research in the Division includes scientific studies focused on the causes of leukemia and brain tumors that have identified new genetic changes resulting in cancer formation. Additional studies have focused on how leukemia cells escape the immune system in the bone marrow. Together, these studies help us understand the causes of childhood cancer and point us to new ways to diagnose and treat these diseases.
The translational research in the Division is focused on identifying new treatment options for childhood cancers and blood disorders. New therapeutic approaches for pediatric leukemia, brain tumors, sarcomas, and neuroblastoma have been pushed forward from our research labs into the clinic. We also have active studies aimed at improving the treatment of childhood blood disorders, including iron deficiency anemia and sickle cell disease.
Explore our basic & translational research initiatives
We pursue life-saving initiatives for children across the globe. Not only does this further our own research, educational, and clinical goals, but it also brings our world-class medical practice to parts of the world that need additional support.
Explore our global research initiatives
Earlier this month, Dr. Robyn Gartrell, a Pediatric Hematology/Oncology Fellow here, traveled to National Harbor, MD, for a conference on immunotherapy. Thanks to Robyn, we can now present this summary of the work being done at Columbia University Medical Center and how it relates to childhood cancer.
Kenneth Nurse was 17 when he was diagnosed with Hodgkin’s Lymphoma. Now 23, he is a patient of Jennifer Levine, MD, at our Center for Survivor Wellness. He is currently a student at CUNY Brooklyn majoring in Psychology and is also a huge soccer fan.
A few weeks ago, our founder, Dr. Michael Weiner, received a birthday party invitation that had him near tears. It was from the family of a patient named Billy Cameron, whom he had treated over 35 years ago.
